Celltrion To Begin Denosumab Trials Within Days

Plans To Complete Trials Before Prolia’s Patent Expires

Clinical_Trial
Celltrion will start denosumab Phase I trials in September • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products